981 related articles for article (PubMed ID: 31575706)
1.
Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
[TBL] [Abstract][Full Text] [Related]
2. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
3. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
Saeed U; Mirza SS; MacIntosh BJ; Herrmann N; Keith J; Ramirez J; Nestor SM; Yu Q; Knight J; Swardfager W; Potkin SG; Rogaeva E; St George-Hyslop P; Black SE; Masellis M
Alzheimers Dement; 2018 Sep; 14(9):1137-1147. PubMed ID: 29782824
[TBL] [Abstract][Full Text] [Related]
4. APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
Brickman AM; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Provenzano FA; Narkhede A; Razlighi Q; Collins-Praino L; Artero S; Akbaraly TN; Ritchie K; Mayeux R; Portet F
Alzheimers Dement; 2014 Nov; 10(6):619-29. PubMed ID: 25304991
[TBL] [Abstract][Full Text] [Related]
5. Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI.
Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
J Neuroimaging; 2016; 26(1):144-9. PubMed ID: 25678236
[TBL] [Abstract][Full Text] [Related]
6. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
[TBL] [Abstract][Full Text] [Related]
7. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
8. Influence of regional white matter hyperintensity volume and apolipoprotein E ε4 status on hippocampal volume in healthy older adults.
Van Etten EJ; Bharadwaj PK; Hishaw GA; Huentelman MJ; Trouard TP; Grilli MD; Alexander GE
Hippocampus; 2021 May; 31(5):469-480. PubMed ID: 33586848
[TBL] [Abstract][Full Text] [Related]
9. Affect of APOE on information processing speed in non-demented elderly population: a preliminary structural MRI study.
Luo X; Jiaerken Y; Yu X; Huang P; Qiu T; Jia Y; Sun J; Zhou J; Zhang M;
Brain Imaging Behav; 2017 Aug; 11(4):977-985. PubMed ID: 27444731
[TBL] [Abstract][Full Text] [Related]
10. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
[TBL] [Abstract][Full Text] [Related]
11. APOE4 and Confluent White Matter Hyperintensities Have a Synergistic Effect on Episodic Memory Impairment in Prodromal Dementia.
Kumar D; Yatawara C; Wang B; Wong B; Tan YJ; Zailan FZ; Ng KP; Kandiah N
J Alzheimers Dis; 2022; 87(3):1103-1114. PubMed ID: 35431245
[TBL] [Abstract][Full Text] [Related]
12.
Sun J; Zhu Z; Chen K; Wei D; Li X; Li H; Zhang J; Chen X; Chen Y; Zhang Z
Aging (Albany NY); 2020 Jun; 12(12):12019-12031. PubMed ID: 32572010
[TBL] [Abstract][Full Text] [Related]
13. Education, APOE ε4, and Cognition in Individuals with Subjective Cognitive Decline with Worry in the SILCODE Study.
Chen G; Lin L; Yang K; Han Y
Curr Alzheimer Res; 2021; 18(6):492-498. PubMed ID: 34598665
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
15. Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment.
Chung SJ; Jeon S; Yoo HS; Lee YH; Yun M; Lee SK; Lee PH; Sohn YH; Evans AC; Ye BS
J Alzheimers Dis; 2020; 73(3):873-885. PubMed ID: 31868668
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
Wolk DA; Dickerson BC;
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
[TBL] [Abstract][Full Text] [Related]
17. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
18. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults.
Jung Y; Viviano RP; van Rooden S; van der Grond J; Rombouts SARB; Damoiseaux JS
J Alzheimers Dis; 2021; 84(3):1337-1350. PubMed ID: 34657884
[TBL] [Abstract][Full Text] [Related]
19. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
